An OECD document has been released that details the state of the science in alternative testing strategies (which reduce or replace the use of animal testing), in relation to the risk assessment of manufactured nanomaterials (MNs). It considers the use of alternative testing strategies in a risk analysis context to inform on human and ecosystem health, and discusses exposure data needs for MNs. The aim is to “expedite the ability to identify high-risk MNs, and lead to more rapid, cost-effective, and reliable MN safety testing for specific risk management decision contexts”.

Organisation for Economic Co-operation and Development (2016). Alternative testing strategies in risk assessment of manufactured nanomaterials: current state of knowledge and research needs to advance their use. Series on the Safety of Manufactured Nanomaterials No 80. ENV/JM/MONO(2016)63. http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV/JM/MONO(2016)63&doclanguage=en

 

The above items were taken from the May 2017 issue of Toxicology and Regulatory News which is sent automatically to members of bibra.

News Home Guest Write For Us? Contact Us